insights_auto
Prečo akcie BT3 klesli 5,17%?
Preskúmať podrobnejšiechevron_right
BT3:FRA
Lineage Cell Therapeutics Inc
0,79 €
arrow_downward
-5,17%(-0,043) 1 d.
14. 10., 8:01:17 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre BT3…
Otvoriť
0,79 €
Vysoká
0,79 €
Nízka
0,79 €
Trh. kap.
228,78 mil.
Priem. obj.
37,00
Objem
0,00
Max. za 52 týž.
1,69 €
Min. za 52 týž.
0,78 €
Počet zamestnancov
75
Otvoriť
0,79 €
Vysoká
0,79 €
Nízka
0,79 €
Trh. kap.
228,78 mil.
Priem. obj.
37,00
Objem
0,00
Max. za 52 týž.
1,69 €
Min. za 52 týž.
0,78 €
Počet zamestnancov
75
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Seeking Alpha
·
pred 1 hodinou
Nasdaq tumbles 2%, and these 10 stocks have fueled the selloff
ChartMill
·
pred 22 minútami
Discover which dow jones stocks are making waves on Wednesday.
MarketBeat
·
pred 28 minútami
IBEX Limited (NASDAQ:IBEX) Sees Significant Drop in Short Interest
Profil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Informácie o subjekte Lineage Cell Therapeutics Inc